NO942376D0 - - Google Patents

Info

Publication number
NO942376D0
NO942376D0 NO942376A NO942376A NO942376D0 NO 942376 D0 NO942376 D0 NO 942376D0 NO 942376 A NO942376 A NO 942376A NO 942376 A NO942376 A NO 942376A NO 942376 D0 NO942376 D0 NO 942376D0
Authority
NO
Norway
Prior art keywords
alkyl
represents hydrogen
halo
alkoxy
pct
Prior art date
Application number
NO942376A
Other languages
English (en)
Norwegian (no)
Other versions
NO942376L (no
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of NO942376L publication Critical patent/NO942376L/no
Publication of NO942376D0 publication Critical patent/NO942376D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO942376A 1991-12-23 1994-06-22 Terapeutiske midler NO942376L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919127252A GB9127252D0 (en) 1991-12-23 1991-12-23 Therapeutic agents
PCT/EP1992/002901 WO1993013097A1 (fr) 1991-12-23 1992-12-12 Derives de naphtyridine antirhumatismaux
CN93109454A CN1096784A (zh) 1991-12-23 1993-06-22 含取代4(5)-氨基-1,8-二氨杂萘的治疗剂

Publications (2)

Publication Number Publication Date
NO942376L NO942376L (no) 1994-06-22
NO942376D0 true NO942376D0 (fr) 1994-06-22

Family

ID=36822317

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942376A NO942376L (no) 1991-12-23 1994-06-22 Terapeutiske midler

Country Status (22)

Country Link
US (1) US5464781A (fr)
EP (1) EP0618916B1 (fr)
JP (1) JP2527917B2 (fr)
CN (1) CN1096784A (fr)
AT (1) ATE171452T1 (fr)
AU (1) AU656832B2 (fr)
BG (1) BG98813A (fr)
CA (1) CA2125858A1 (fr)
CZ (1) CZ153594A3 (fr)
DE (1) DE69227125T2 (fr)
FI (1) FI943019A0 (fr)
GB (1) GB9127252D0 (fr)
HR (1) HRP921455A2 (fr)
HU (1) HUT66971A (fr)
IL (1) IL104169A0 (fr)
IN (1) IN174405B (fr)
MX (1) MX9207494A (fr)
NO (1) NO942376L (fr)
NZ (1) NZ246156A (fr)
SI (1) SI9200408A (fr)
SK (1) SK75094A3 (fr)
WO (1) WO1993013097A1 (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9312891D0 (en) * 1993-06-22 1993-08-04 Boots Co Plc Therapeutic agents
GB9318931D0 (en) * 1993-09-14 1993-10-27 Boots Co Plc Therapeutic agents
GB9420168D0 (en) * 1994-10-06 1994-11-23 Boots Co Plc Therapeutic agents
AR004010A1 (es) 1995-10-11 1998-09-30 Glaxo Group Ltd Compuestos heterociclicos
AU733551B2 (en) 1996-09-25 2001-05-17 Astrazeneca Ab Qinoline derivatives inhibiting the effect of growth factors such as VEGF
RS49779B (sr) 1998-01-12 2008-06-05 Glaxo Group Limited, Biciklična heteroaromatična jedinjenja kao inhibitori protein tirozin kinaze
US6166069A (en) * 1998-05-12 2000-12-26 American Home Products Corporation Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
WO2001004111A1 (fr) 1999-07-09 2001-01-18 Glaxo Group Limited Anilino-quinazolines comme inhibiteurs de la proteine tyrosine kinase
US6933299B1 (en) 1999-07-09 2005-08-23 Smithkline Beecham Corporation Anilinoquinazolines as protein tyrosine kinase inhibitors
EP1274692B1 (fr) 2000-04-07 2006-08-02 AstraZeneca AB Composes a base de quinazoline
US6534656B2 (en) * 2001-05-31 2003-03-18 North Carolina State University Short synthesis of pyridine-based pharmaceutical intermediates
JP2003329989A (ja) * 2002-03-06 2003-11-19 Nippon Telegr & Teleph Corp <Ntt> 光送信装置
GB0230018D0 (en) 2002-12-23 2003-01-29 Syngenta Ltd Fungicides
EP1660092A2 (fr) 2003-07-03 2006-05-31 Myriad Genetics, Inc. 4-arylamino-quinazolines comme activateurs de caspases et inducteurs d'apoptose
US8309562B2 (en) * 2003-07-03 2012-11-13 Myrexis, Inc. Compounds and therapeutical use thereof
KR100807920B1 (ko) 2003-12-23 2008-02-27 화이자 인코포레이티드 신규한 퀴놀린 유도체
EP1833482A4 (fr) 2005-01-03 2011-02-16 Myriad Genetics Inc Composés bicycliques azotés et utilisation thérapeutique associée
US8258145B2 (en) * 2005-01-03 2012-09-04 Myrexis, Inc. Method of treating brain cancer
US7763731B2 (en) * 2005-12-21 2010-07-27 Abbott Laboratories Anti-viral compounds
EP1971611B1 (fr) * 2005-12-21 2012-10-10 Abbott Laboratories Composes anti-viraux
ES2378473T3 (es) * 2005-12-21 2012-04-12 Abbott Laboratories Compuestos antivirales
EP2345652A1 (fr) 2005-12-21 2011-07-20 Abbott Laboratories Composées antivirales
TWI392677B (zh) * 2005-12-21 2013-04-11 Abbott Lab 抗病毒化合物、其製備方法及用途
TWI399380B (zh) 2006-12-20 2013-06-21 Abbott Lab 抗病毒化合物
US20110269758A1 (en) * 2008-07-03 2011-11-03 Merck Patent Gmbh Naphthyridinones as protein kinase inhibitors
EP2401275B1 (fr) 2009-02-24 2013-07-24 Respiratorius AB Dérivés de naphthyridine à activité bronchodilatatoire
WO2011063398A1 (fr) * 2009-11-23 2011-05-26 Cylene Pharamaceuticals, Inc. Polymorphes et sels d'un inhibiteur de kinase
BR112012025167B1 (pt) 2010-04-02 2024-01-09 Firmenich Incorporated Modificador de sabor doce

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4466965A (en) * 1982-07-26 1984-08-21 American Hospital Supply Corporation Phthalazine compounds, compositions and use
NO174506B (no) * 1984-10-30 1994-02-07 Usv Pharma Corp Analogifremgangsmaate ved fremstilling av terapeutisk aktive forbindelser
EP0222839A4 (fr) * 1985-05-17 1988-11-09 Univ Australian Composes antipaludiques.
JPS6368568A (ja) * 1986-09-10 1988-03-28 Otsuka Pharmaceut Factory Inc ｐ−アミノフエノ−ル誘導体
DE3644825A1 (de) * 1986-12-31 1988-07-14 Basf Ag Substituierte 1,8-naphthyridin-derivate und diese enthaltende fungizide
WO1989000571A2 (fr) * 1987-07-22 1989-01-26 Schering Corporation Composes bicycliques, leur utilisation comme produits pharmaceutiques, leur preparation et composes intermediaires utiles dans leur preparation
GB8804443D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
US4978661A (en) * 1988-09-29 1990-12-18 Innocenzo Caruso Use of 6-halo-4-quinolone compounds and pharmaceutical compositions thereof for the preparation of a medicament for the therapeutical application in rheumatoid arthritis
GR900100380A (el) * 1989-05-20 1991-10-10 Fisons Plc Μέ?οδος παρασκευής αντι-φλεγμονωδών παραγώγων αμινοφενόλης.
AU634561B2 (en) * 1989-07-27 1993-02-25 Eli Lilly And Company Naphthyridine derivatives
JP2988739B2 (ja) * 1990-04-16 1999-12-13 協和醗酵工業株式会社 １，８−ナフチリジン−２−オン誘導体
JP3157077B2 (ja) * 1994-02-16 2001-04-16 内山工業株式会社 ベアリングシール

Also Published As

Publication number Publication date
FI943019A (fi) 1994-06-22
AU3158793A (en) 1993-07-28
MX9207494A (es) 1993-07-01
HUT66971A (en) 1995-01-30
CA2125858A1 (fr) 1993-07-08
NO942376L (no) 1994-06-22
SI9200408A (en) 1993-09-30
CN1096784A (zh) 1994-12-28
HRP921455A2 (en) 1994-12-31
JP2527917B2 (ja) 1996-08-28
CZ153594A3 (en) 1995-02-15
IN174405B (fr) 1994-11-26
US5464781A (en) 1995-11-07
NZ246156A (en) 1996-01-26
HU9401877D0 (en) 1994-09-28
WO1993013097A1 (fr) 1993-07-08
IL104169A0 (en) 1993-05-13
DE69227125T2 (de) 1999-02-18
DE69227125D1 (de) 1998-10-29
EP0618916B1 (fr) 1998-09-23
SK75094A3 (en) 1995-04-12
ATE171452T1 (de) 1998-10-15
JPH07502280A (ja) 1995-03-09
BG98813A (bg) 1995-05-31
AU656832B2 (en) 1995-02-16
FI943019A0 (fi) 1994-06-22
GB9127252D0 (en) 1992-02-19
EP0618916A1 (fr) 1994-10-12

Similar Documents

Publication Publication Date Title
IN174405B (fr)
DK41193D0 (da) Ionkanalaabnere
MY129425A (en) Indole derivatives useful a.o. for the treatment of osteoporosis
AU2246292A (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
GB9121456D0 (en) Triazole antifungal agents
GB9305641D0 (en) Therapeutic agents
DE69720715D1 (en) Hexahydro-pyrido (4,3-b)indolderivate als antipsychotische arzneimittel
PH30660A (en) Therapeutic agents
HU9402466D0 (en) Indole derivatives as steroid-5-alpha-reductase inhibitors
NO933241L (no) Aminosyrer nyttige ved terapi av osteoartikulaere paavirkninger
JO1754B1 (en) Therapeutic agents
AUPO227896A0 (en) Novel compounds and their preparation
ZA952403B (en) New 2,4-diphosphonoglutaric acid derivatives processes for their production and pharmaceutical agents containing these compounds
AU2796695A (en) Pyrrolidine derivatives for the treatment of cholecystokinine and gastrine-related disorders
JO1810B1 (en) Therapeutic agents
HU9500710D0 (en) Ureido-acetamide derivatives, preparation thereof and drugs containing same
JO1755B1 (en) Therapeutic agents
MX9705218A (es) Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis de ginecomastia idiopatica o fisiologica.
MX9705378A (es) Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis de la obesidad.